Abstract
Mesenchymal and neuronal neoplasms are often difficult to identify clinically. Color, location, and palpation findings of the lesion are helpful for differential diagnosis. According to the anatomical localization of mesenchymal structures, a distinction is made between neoplasms of connective tissue and fatty tissue, smooth and striated musculature, cartilage tissue and bone tissue, as well as of the peripheral nervous system. A representative tissue sample with dermatohistopathological examination is often indispensable for the precise classification of these lesions. Numerous immunohistochemical markers have proven their worth in this context. With the introduction of molecular biology, fluorescence-in-situ hybridization and reverse transcriptase-polymerase chain reactions have also become diagnostic tools for many entities. In addition, in a number of malignant neoplasms, chromosomal aberrations have prognostic and therapeutic relevance.
References
Connective Tissue
Abdaljaleel MY, North JP (2017) Sclerosing dermatofibrosarcoma protuberans shows significant overlap with sclerotic fibroma in both routine and immunohistochemical analysis: a potential diagnostic pitfall. Am J Dermatopathol 39:83–88
Agaimy A, Haller F (2016) CTNNB1 (β-Catenin)-altered neoplasia: a review focusing on soft tissue neoplasms and parenchymal lesions of uncertain histogenesis. Adv Anat Pathol 23:1–12
Agaimy A, Bieg M, Michal M et al (2017) Recurrent somatic PDGFRB mutations in sporadic infantile/solitary adult myofibromas but not in angioleiomyomas and myopericytomas. Am J Surg Pathol 41:195–203
Allen PW, Dymock RB, MacCormac LB (1988) Superficial angiomyxomas with and without epithelial components. Am J Surg Pathol 12:519–530
Antal A, Zelger B, Reifenberger J et al (2007) Multiple eruptive myxoid dermatofibromas: report of first case and review of literature. Br J Dermatol 157:382–385
Arts FA, Sciot R, Brichard B et al (2017) PDGFRB gain-of-function mutations in sporadic infantile myofibromatosis. Hum Mol Genet 26:1801–1810
Bansal C, Stewart D, Li A et al (2005) Histologic variants of fibrous papule. J Cutan Pathol 32:424–428
Boland JM, Folpe AL (2017) Hemosiderotic fibrolipomatous tumor, pleomorphic hyalinizing angiectatic tumor, and myxoinflammatory fibroblastic sarcoma: related or not? Adv Anat Pathol 24:268–277
Charli-Joseph Y, Saggini A, Doyle LA et al (2014) DNA copy number changes in tumors within the spectrum of cellular, atypical, and metastasizing fibrous histiocytoma. J Am Acad Dermatol 71:256–263
Di Vito A, Scali E, Ferraro G et al (2015) Elastofibroma dorsi: a histochemical and immunohistochemical study. Eur J Histochem 59:2459. https://doi.org/10.4081/ejh.2015.2459
Dickson BC, Swanson D, Charames GS et al (2018) Epithelioid fibrous histiocytoma: molecular characterization of ALK fusion partners in 23 cases. Mod Pathol 31:753–762
Doyle LA, Fletcher CD (2013) Metastasizing “benign” cutaneous fibrous histiocytoma: a clinicopathologic analysis of 16 cases. Am J Surg Pathol 37:484–495
Doyle LA, Marino-Enriquez A, Fletcher CDM et al (2015) ALK rearrangement and overexpression in epithelioid fibrous histiocytoma. Mod Pathol 28:904–912
Erdag G, Qureshi HS, Patterson JW et al (2007) Solitary fibrous tumors of the skin: a clinicopathologic study of 10 cases and review of the literature. J Cutan Pathol 34:844–850
Feasel P, Al-Ibraheemi A, Fritchie K et al (2018) Superficial solitary fibrous tumor: a series of 26 cases. Am J Surg Pathol 42:778–785
Felty CC, Linos K (2019) Epithelioid fibrous histiocytoma: a concise review. Am J Dermatopathol 41:879–883
Folpe AL (2014) Fibrosarcoma: a review and update. Histopathology 64:12–25
Frezza AM, Jones RL, Lo Vullo S et al (2018) Anthracycline, gemcitabine, and pazopanib in epithelioid sarcoma: a multi-institutional case series. JAMA Oncol 4:e180219
Gawron K, Lazarz-Bartyzel K, Potempa J et al (2016) Gingival fibromatosis: clinical, molecular and therapeutic issues. Orphanet J Rare Dis 11:9. https://doi.org/10.1186/s13023-016-0395-1
Gengler C, Guillou L (2006) Solitary fibrous tumour and haemangiopericytoma: evolution of a concept. Histopathology 48:63–74
Gray MH, Smoller BR, McNutt NS et al (1990) Giant dermal dendrocytoma of the face: a distinct clinicopathologic entity. Arch Dermatol 126:689–690
Griewank KG, Schilling B, Murali R et al (2014) TERT promotor mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas. Mod Pathol 27:502–508
Griewank KG, Wiesner T, Murali R et al (2018) Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1/2 and FAT1 mutations and similar DNA copy number alteration profiles. Mod Pathol 31:418–428
Grynspan D, Meir K, Senger C et al (2007) Cutaneous changes in fibrous hamartoma of infancy. J Cutan Pathol 34:39–43
Helbig D, Ihle MA, Pütz K et al (2016) Oncogene and therapeutic target analyses in atypical fibroxanthomas and pleomorphic dermal sarcomas. Oncotarget 7:21763–21774
Hinds B, Agulló Pérez AD, LeBoit PE et al (2017) Loss of retinoblastoma in pleomorphic fibroma: an immunohistochemical and genomic analysis. J Cutan Pathol 44:665–671
Kasper B, Baumgarten C, Garcia J et al (2017) An update on the management of sporadic desmoid-type fibromatosis: a European consensus initiative between sarcoma patients euronet (SPAEN) and European organization for research and treatment of cancer (EORTC)/soft tissue and bone sarcoma group (STBSG). Ann Oncol 28:2399–2408
Kazakov DV, Kyrpychova L, Martinek P et al (2018) ALK gene fusions in epithelioid fibrous histiocytoma: a study of 14 cases, with new histopathological findings. Am J Dermatopathol 40:805–814
Luzar B, Calonje E (2009) Superficial acral fibromyxoma: clinicopathological study of 14 cases with emphasis on a cellular variant. Histopathology 54:375–377
Mansoor A, White CR Jr (2003) Myxofibrosarcoma presenting in the skin: clinicopathological features and differential diagnosis with cutaneous myxoid neoplasms. Am J Dermatopathol 25:281–286
Martignetti JA, Tian L, Li D et al (2013) Mutations in PDGFRB cause autosomal dominant infantile myofibromatosis. Am J Hum Genet 92:1001–1007
Martin L, Piette F, Blanc P et al (2005) Clinical variants of the preprotuberant stage of dermatofibrosarcoma protuberans. Br J Dermatol 153:932–936
Mentzel T, Schärer L, Kazakov DV et al (2007) Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases. Am J Dermatopathol 29:443–448
Mentzel T, Wiesner T, Cerroni L et al (2013) Malignant dermatofibroma: clinicopathological, immunohistochemical, and molecular analysis of seven cases. Mod Pathol 26:256–267
Miller K, Goodlad JR, Brenn T (2012) Pleomorphic dermal sarcoma: adverse histologic features predict aggressive behavior and allow distinction from atypical fibroxanthoma. Am J Surg Pathol 36:1317–1326
Navarrete-Dechent C, Mori S, Barker CA et al (2019) Imatinib treatment for locally advanced or metastatic dermatofibrosarcoma protuberans: a systematic review. JAMA Dermatol 155:361–369
Nickoloff BJ, Wood GS, Chu M et al (1990) Disseminated dermal dendrocytomas. A new cutaneous fibrohistiocytic proliferative disorder? Am J Surg Pathol 14:867–871
Nishi SP, Brey NV, Sanchez RL (2006) Dermal nodular fasciitis: three case reports of the head and neck and literature review. J Cutan Pathol 33:378–382
Parham DM (2018) Fibroblastic and myofibroblastic tumors of children: new genetic entities and new ancillary testing. F1000Res 7. pii: F1000 Faculty Rev- 1963. https://doi.org/10.12688/f1000research.16236.1. eCollection
Park JY, Cohen C, Lopez D et al (2016) EGFR exon 20 insertion/duplication mutations characterize fibrous hamartoma of infancy. Am J Surg Pathol 40:1713–1718
Puls F, Hofvander J, Magnusson L et al (2016) FN1-EGF gene fusions are recurrent in calcifying aponeurotic fibroma. J Pathol 238:502–507
Saab ST, McClain CM, Coffin CM (2014) Fibrous hamartoma of infancy: a clinicopathologic analysis of 60 cases. Am J Surg Pathol 38:394–401
Shah KN, Anderson E, Junkins-Hopkins J et al (2007) Medallion-like dermal dendrocyte hamartoma. Pediatr Dermatol 24:632–636
Spaun E, Zelger B (2009) Dermatofibroma with intracytoplasmic eosinophilic globules: an unusual phenomenon. J Cutan Pathol 36:796–798
Tap WD, Wainberg ZA, Anthony SP et al (2015) Structure-guided blockade of CSF1R kinase in tenosynovial giant-cell tumor. N Engl J Med 373:428–437
Tardio JC, Pinedo F, Aramburu JA et al (2016) Pleomorphic dermal sarcoma: a more aggressive neoplasm than previously estimated. J Cutan Pathol 43:101–112
Thway K, Fisher C (2015) Angiomatoid fibrous histiocytoma: the current status of pathology and genetics. Arch Pathol Lab Med 139:674–682
Thway K, Jones RL, Noujaim J et al (2016a) Epithelioid sarcoma: diagnostic features and genetics. Adv Anat Pathol 23:41–49
Thway K, Ng W, Noujaim J et al (2016b) The current status of solitary fibrous tumor: diagnostic features, variants, and genetics. Int J Surg Pathol 24:281–292
Vivero M, Doyle LA, Fletcher CD et al (2014) GRIA2 is novel diagnostic marker for solitary fibrous tumour identified through gene expression profiling. Histopathology 65:71–80
Wang Z, Wu J, Tian X et al (2019) Targeted therapy of desmoid-type fibromatosis: mechanism, current situation, and future prospects. Front Med 13:427–437
Warren RB, Verbov JL, Ashworth M (2007) Precalcaneal congenital fibrolipomatous hamartoma. Pediatr Dermatol 24:74–75
Weinstein JM, Drolet BA, Esterly NB et al (2003) Congenital dermatofibrosarcoma protuberans: variability in presentation. Arch Dermatol 139:207–211
Wilk M, Schmoeckel C, Kaiser HW et al (1995) Cutaneous angiomyxoma: a benign neoplasm distinct from cutaneous focal mucinosis. J Am Acad Dermatol 33:352–355
Wilk M, Zelger BG, Nilles M et al (2004) The value of immunohistochemistry in atypical cutaneous fibrous histiocytoma. Am J Dermatopathol 26:367–371
Wilk M, Zelger BG, Debiec-Rychter M et al (2015) Angiomatoid fibrous histiocytoma – case series with emphasis on a late fibrotic variant. J Dtsch Dermatol Ges 13:441–448
Wilk M, Zelger BG, Zelger B (2015b) Fibrosarcomatous dermatofibrosarcoma protuberans with myoid nodules. J Cutan Pathol 42:782–785
Wilk M, Zelger BG, Zelger B (2016) Hemosiderotic fibrolipomatous tumor. Am J Dermatopathol 38:714–716
Wilson Jones E, Cerio R, Smith NP (1989) Epithelioid cell histiocytoma: a new entity. Br J Dermatol 120:185–195
Yu G, Wang Y, Wang G et al (2015) Fibrous hamartoma of infancy: a clinical pathological analysis of seventeen cases. Int J Clin Exp Pathol 8:3374–3377
Zelger B, Soyer HP (2000) Between Scylla and Charybdis: mythology in dermatopathology. Dermatopathol Pract Concept 6:348–355
Zelger BG, Zelger B (2001) Skin lesions of fibrocytic and fibrohistiocytic differentiation: a new concept and classification. Curr Top Pathol 94:103–140
Zelger BW, Steiner H, Kutzner H (1996) Clear cell dermatofibroma. Case report of an unusual fibrohistiocytic lesion. Am J Surg Pathol 20:483–491
Zelger B, Zelger BG, Burgdorf WH (2004) Dermatofibroma – a critical evaluation. Int J Surg Pathol 12:333–344
Fatty Tissue
Billings SD, Folpe AL (2007) Diagnostically challenging spindle cell lipomas: a report of 34 “low-fat” and “fat-free” variants. Am J Dermatopathol 29:437–442
Chen BJ, Marino-Enriquez A, Fletcher CD et al (2012) Loss of retinoblastoma protein expression in spindle cell/pleomorphic lipomas and cytogenetically related tumors: an immunhistochemical study with diagnostic implications. Am J Surg Pathol 36:1119–1128
Dei Tos AP, Mentzel T, Fletcher CD (1998) Primary liposarcoma of the skin: a rare neoplasm with unusual high grade features. Am J Dermatopathol 20:332–338
Evans HL (1979) Liposarcoma. A study of 55 cases with reassessment of its classification. Am J Surg Pathol 3:507–523
Hofvander J, Arbajian E, Stenkula KG et al (2017) Frequent low-level mutations of protein kinase D2 in angiolipoma. J Pathol 241:578–582
Jakhar D, Kaur I, Singal A et al (2019) Precalcaneal congenital fibrolipomatous hamartoma: rare or under-reported? J Cutan Pathol 46:277–279
Lee ATJ, Thway K, Huang PH et al (2018) Clinical and molecular spectrum of liposarcoma. J Clin Oncol 36:151–159
Leffell DJ, Braverman IM (1986) Familial multiple lipomatosis. Report of a case and review of the literature. J Am Acad Dermatol 15:275–279
Marek T, Spinner RJ, Syal A et al (2019) Surgical treatment of lipomatosis of nerve: a systematic review. World Neurosurg 128:587–592.e2
Marino-Enriquez A, Nascimento AF, Ligon AH et al (2017) Atypical spindle cell lipomatous tumor: clinicopathologic characterization of 232 cases demonstrating a morphologic spectrum. Am J Surg Pathol 41:234–244
Nishio J (2011) Contributions of cytogenetics and molecular cytogenetics to the diagnosis of adipocytic tumors. J Biomed Biotechnol 2011:524067. Epub 11 Jan 2011 Review
Wilk M, Zelger BG, Zelger B (2013) Adenolipoma – eccrine and apocrine variants with evidence for a hamartomatous process. Am J Dermatopathol 35:138–141
Smooth Muscle
Alam NA, Barclay E, Rowan AJ et al (2005) Clinical features of multiple cutaneous and uterine leiomyomatosis: an underdiagnosed tumor syndrome. Arch Dermatol 141:199–206
Badeloe S, van Geel M, van Steensel MA et al (2006) Diffuse and segmental variants or cutaneous leiomyomatosis: novel mutations in the fumarate hydratase gene and review of the literature. Exp Dermatol 15:735–741
Bhola PT, Gilpin C, Smith A et al (2018) A retrospective review of 48 individuals, including 12 families, molecularly diagnosed with hereditary leiomyomatosis and renal cell cancer (HLRCC). Familial Cancer 17:615–620
Hachisuga T, Hashimoto H, Enjoji M (1984) Angioleiomyoma. A clinicopathologic reappraisal of 562 cases. Cancer 54:126–130
Holst VA, Junkins-Hopkins JM, Elenitsas R (2002) Cutaneous smooth muscle neoplasms: clinical features, histologic findings, and treatment options. J Am Acad Dermatol 46:477–490
Kienast A, Maerker J, Hoeger PH (2007) Myokymia as a presenting sign of congenital smooth muscle hamartoma. Pediatr Dermatol 24:628–631
Kraft S, Fletcher CDM (2011) Atypical intradermal smooth muscle neoplasms: clinicopathologic analysis of 84 cases and a reappraisal of cutaneous “leiomyosarcoma”. Am J Surg Pathol 35:599–607
Patel VM, Handler MZ, Schwartz RA et al (2017) Hereditary leiomyomatosis and renal cell cancer syndrome: an update and review. J Am Acad Dermatol 77:149–158
Winchester DS, Hocker TL, Roenigk RK (2015) Skin metastases of leiomyosarcoma (LMS): a retrospective review of 21 cases. J Am Acad Dermatol 72:910–912
Striated Muscle
Alaggio R, Zhang L, Sung YS et al (2016) A molecular study of pediatric spindle and sclerosing rhabdomyosarcoma: identification of novel and recurrent VGLL2-related fusions in infantile cases. Am J Surg Pathol 40:224–235
Chang Y, Dehner LP, Egbert B (1990) Primary cutaneous rhabdomyosarcoma. Am J Surg Pathol 14:977–982
Farris PE, Manning S, Vuitch F (1994) Rhabdomyomatous mesenchymal hamartoma. Am J Dermatopathol 16:73–74
Lee KA, Won H-S, Shim J-Y et al (2013) Molecular genetic, cardiac and neurodevelopmental findings in cases of prenatally diagnosed rhabdomyoma associated with tuberous sclerosis complex. Ultrasound Obstet Gynecol 41:306–311
Missiaglia E, Williamson D, Chisholm J et al (2012) PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification. J Clin Oncol 30:1670–1677
Pavlicek J, Klaskova E, Kapralova S et al (2019) Fetal heart rhabdomyomatosis: a single-center experience. J Matern Fetal Neonatal Med 1–7. https://doi.org/10.1080/14767058.2019.1613365. [Epub ahead of print]
Rosenberg AS, Kirk J, Morgan MB (2002) Rhabdomyomatous mesenchymal hamartoma: an unusual dermal entity with a report of two cases and a review of the literature. J Cutan Pathol 29:238–243
Szuhai K, de Jong D, Leung WY et al (2014) Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma. J Pathol 232:300–307
Walther C, Mayrhofer M, Nilsson J et al (2016) Genetic heterogeneity in rhabdomyosarcoma revealed by SNP array analysis. Genes Chromosomes Cancer 55:3–15
Cartilage and Bone
Conlin PA, Jimenez-Quintero LP, Rapini RP (2002) Osteomas of the skin revisited: a clinicopathologic review of 74 cases. Am J Dermatopathol 24:479–483
Conner JR, Hornick JL (2013) SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours. Histopathology 63:36–49
Jour G, Wang L, Middha S et al (2015) The molecular landscape of extraskeletal osteosarcoma: a clinicopathological and molecular biomarker study. J Pathol Clin Res 2:9–20
Kobos JW, Yu GH, Varadarajan S et al (1995) Primary cutaneous osteosarcoma. Am J Dermatopathol 17:53–57
Larsen S, Davis DM, Comfere NI et al (2010) Osteosarcoma of the skin. Int J Dermatol 49:532–540
Longhi A, Bielack SS, Grimer R et al (2017) Extraskeletal osteosarcoma: a European musculoskeletal oncology society study on 266 patients. Eur J Cancer 74:9–16
Mantovani G, Spada A, Elli FM (2016) Pseudohypoparathyroidism and Gsα-cAMP-linked disorders: current view and open issues. Nat Rev Endocrinol 12:347–356
Meng T, Jin J, Jiang C et al (2019) Molecular targeted therapy in the treatment of chordoma: a systematic review. Front Oncol 9:30. https://doi.org/10.3389/fonc.2019.00030. eCollection 2019
Palm RF, Oliver DE, Yang GQ et al (2019) The role of dose escalation and proton therapy in perioperative or definitive treatment of chondrosarcoma and chordoma: an analysis of the national cancer data base. Cancer 125:642–651
Sakai JN, Abe KT, Formigli LM et al (2011) Cytogenetic findings in 14 benign cartilaginous neoplasms. Cancer Genet 204:180–186
Thiele S, Mantovani G, Barlier A et al (2016) From pseudohypoparathyroidism to inactivating PTH/PTHrP signaling disorder (iPPSD), a novel classification proposed by the EuroPHP network. Eur J Endocrinol 175:P1–P17
Toida M, Sugiyama T, Kato Y (2003) Cartilaginous choristoma of the tongue. J Oral Maxillofac Surg 61:393–396
Wentworth KL, Masharani U, Hsiao EC (2019) Therapeutic advances for blocking heterotopic ossification in fibrodysplasia ossificans progressiva. Br J Clin Pharmacol 85:1180–1187
Peripheral Nervous System
Agnihotri S, Jalali S, Wilson MR et al (2016) The genomic landscape of schwannoma. Nat Genet 48:1339–1348
Becker JC, Stang A, DeCaprio JA et al (2017) Merkel cell carcinoma. Nat Rev Dis Primers 3:17077. https://doi.org/10.1038/nrdp.2017.77. Review
Brekke HR, Ribeiro FR, Kolberg M et al (2010) Genomic changes in chromosomes 10, 16, and X in malignant peripheral nerve sheath tumors identify a high-risk patient group. J Clin Oncol 28:1573–1582
Brock JE, Perez-Atayde AR, Kozakewich HPW et al (2005) Cytogenetic aberrations in perineurioma: variation with subtype. Am J Surg Pathol 29:1164–1169
Dehner LP (1993) Primitive neuroectodermal tumor and Ewing’s sarcoma. Am J Surg Pathol 17:1–13
Gaspard M, Lamant L, Tournier E et al (2018) Evaluation of eight melanocytic and neural crest-associated markers in a well-characterised series of 124 malignant peripheral nerve sheath tumours (MPNST): useful to distinguish MPNST from melanoma? Histopathology 73:969–982
Gupta SG, Wang LC, Penas PF et al (2006) Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature. Arch Dermatol 142:685–690
Harms KL, Healy MA, Nghiem P et al (2016) Analysis of prognostic factors from 9387 Merkel cell carcinoma cases forms the basis for the new 8th edition AJCC Staging System. Ann Surg Oncol 23:3564–3571
Heath M, Jaimes N, Lemos B et al (2008) Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol 58:375–381
Hornick JL, Fletcher CD (2005) Soft tissue perineurioma: clinicopathologic analysis of 81 cases including those with atypical histologic features. Am J Surg Pathol 29:845–858
Jabbari P, Hanaei S, Rezaei N (2019) State of the art in immunotherapy of neuroblastoma. Immunotherapy 11:831–850
Kacerovska D, Michal M, Kazakov DV (2016) Hybrid epithelioid schwannoma/perineurioma. Am J Dermatopathol 38:e90–e92
Kehrer-Sawatzki H, Farschtschi S, Mautner VF et al (2017) The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumor suppressor genes in tumorigenesis. Hum Genet 136:129–148
Klapman MH, Chun D (1991) Cutaneous and subcutaneous neuroblastoma in children and adults: case reports and population study. J Am Acad Dermatol 24:1025–1027
Lebbe C, Becker JC, Grob JJ et al (2015) Diagnosis and treatment of Merkel cell carcinoma. European consensus-based interdisciplinary guideline. Eur J Cancer 51:2396–2403
Lewis KG, Weinstock MA, Weaver AL et al (2006) Adjuvant local irradiation for Merkel cell carcinoma. Arch Dermatol 142:693–700
Louis CU, Shohet JM (2015) Neuroblastoma: molecular pathogenesis and therapy. Annu Rev Med 66:49–63
May C, LeBoit P, McCalmont T et al (2019) Hypercellular encapsulated neuroma imitating desmoplastic melanoma. Am J Dermatopathol 41:358–360
Mentzel T, Kutzner H (2005) Reticular and plexiform perineurioma: clinicopathological and immunohistochemical analysis of two cases and review of perineurial neoplasms of skin and soft tissues. Virchows Arch 447:677–682
Miao R, Wang H, Jacobson A et al (2019) Radiation-induced and neurofibromatosis-associated malignant peripheral nerve sheath tumors (MPNST) have worse outcomes than sporadic MPNST. Radiother Oncol 137:61–70
Miettinen MM, Antonescu CR, Fletcher CDM et al (2017) Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1 patients-a consensus overview. Hum Pathol 67:1–10
Mott RT, Smoller BR, Morgan MB (2004) Merkel cell carcinoma: a clinicopathologic study with prognostic implications. J Cutan Pathol 31:217–223
Requena L, Sangüeza OP (1995) Benign neoplasms with neural differentiation: a review. Am J Dermatopathol 17:75–96
Riethdorf S, Hildebrandt L, Heinzerling L et al (2019) Detection and characterization of circulating tumor cells in patients with Merkel cell carcinoma. Clin Chem 65:462–472
Samimi M (2019) Immune checkpoint inhibitors and beyond: an overview of immune-based therapies in Merkel cell carcinoma. Am J Clin Dermatol 20:391–407
Tashiro A, Imafuku S, Furue M (2008) Traumatic neuroma of the lower lip with intraepithelial nerve fibers. J Cutan Pathol 35:320–323
Tolbert VP, Coggins GE, Maris JM (2017) Genetic susceptibility to neuroblastoma. Curr Opin Genet Dev 42:81–90
Torres-Mora J, Dry S, Li X et al (2014) Malignant melanotic schwannian tumor: a clinicopathologic, immunohistochemical, and gene expression profiling study of 40 cases, with a proposal for the reclassification of “melanotic schwannoma”. Am J Surg Pathol 38:94–105
Various Tumors
Anderson WJ, Hornick JL (2019) Immunohistochemical correlates of recurrent genetic alterations in sarcomas. Genes Chromosomes Cancer 58:111–123
Boyd AS, Rapini RP (1994) Cutaneous collision tumors. An analysis of 69 cases and review of the literature. Am J Dermatopathol 16:253–257
Bridge JA (2014) The role of cytogenetics and molecular diagnostics in the diagnosis of soft-tissue tumors. Mod Pathol 27:S80–S97
Costigan DC, Doyle LA (2016) Advances in the clinicopathologic and molecular classification of cutaneous mesenchymal neoplasms. Histopathology 68:776–795
Elder DE, Massi D, Scolyer RA, Willemze R (eds) (2018) World Health Organization classification of skin tumours. IARC Press, Lyon
Eloy-Garcia Carrasco C, Benguigui Benadiva J, Martinez Garcia S et al (2006) Atypical primary carcinoid tumour of the skin. J Cutan Pathol 33(Suppl 2):32–34
Fletcher CDM (2014) Recently characterized soft tissue tumors that bring biologic insight. Mod Pathol 27:S98–S112
Fletcher CDM, Bridge JA, Hogendoorn PCW et al (eds) (2013) World Health Organization classification of tumours of soft tissue and bone. IARC Press, Lyon
Hornick JL (2014) Novel uses of immunohistochemistry in the diagnosis and classification of soft tissue tumors. Mod Pathol 27:S47–S63
Tran TA, Muller S, Chaudahri PJ et al (2005) Cutaneous carcinosarcoma: adnexal vs. epidermal types define high- and low-risk tumors. Results of a meta-analysis. J Cutan Pathol 32:2–11
First Describer
Abrikossoff A (1926) Über Myome, ausgehend von der quergestreiften willkürlichen Muskulatur. Virchows Arch Pathol Anat 260:215–233
Albright F, Burnett CH, Smith PH et al (1942) Pseudo-hypoparathyroidism: an example of “Seabright-Bantam syndrome”. Endocrinology 30:922–932
Bart RS, Andrade R, Kopf AW et al (1968) Acquired digital fibrokeratomas. Arch Dermatol 97:120–129
Bednar B (1957) Storiform neurofibromas of the skin, pigmented and non-pigmented. Cancer 10:368–376
Chassaignac CME (1852) Cancer de la gaine des tendons. Gaz Hop Civ Mil 47:185
Chung EB, Enzinger FM (1978) Chondroma of soft parts. Cancer 41:1414–1424
Chung EB, Enzinger FM (1979) Fibroma of tendon sheath. Cancer 44:1945–1954
Darier J, Ferrand M (1924) Dermato-fibromes progressifs et récidivants ou fibro-sarcomes de la peau. Ann Dermatol Syphiligr 5:545–562
de Feraudy S, Fletcher CDM (2012) Fibroblastic connective tissue nevus: a rare cutaneous lesion analyzed in a series of 25 cases. Am J Surg Pathol 36:1509–1515
Enzinger FM (1965) Clear cell sarcoma of tendons and aponeuroses: an analysis of 21 cases. Cancer 18:1163–1174
Enzinger FM (1970) Epithelioid sarcoma. A sarcoma simulating a granuloma or a carcinoma. Cancer 26:1029–1041
Enzinger FM (1979) Angiomatoid malignant fibrous histiocytoma: a distinct fibrohistiocytic tumor of children and young adults simulating a vascular neoplasm. Cancer 44:2147–2157
Enzinger FM, Harvey DA (1975) Spindle cell lipoma. Cancer 36:1852–1859
Enzinger FM, Shiraki M (1972) Extraskeletal myxoid chondrosarcoma. An analysis of 34 cases. Hum Pathol 3:421–435
Evans HL (1995) Desmoplastic fibroblastoma. A report of seven cases. Am J Surg Pathol 19:1077–1081
Ewing J (1921) Diffuse endothelioma of bone. Proc NY Pathol Soc 21:17–24
Fetsch JF, Laskin WB, Miettinen M (2001) Superficial acral fibromyxoma: a clinicopathologic and immunohistochemical analysis of 37 cases of a distinctive soft tissue tumor with a predilection for the fingers and toes. Hum Pathol 32:704–714
Fitzpatrick TB, Gilchrest BA (1977) Dimple sign to differentiate benign from malignant pigmented cutaneous lesions. N Engl J Med 296:1518
Frank A (1908) Ein Fall von angeborenen Fibromen am Finger nebst Beiträgen zur Kasuistik von Fingertumoren. Wien Klin Rundsch 22:659
Gery L (1914) Discussions. Bull Mem Soc Anat (Paris) 89:111
Graham JH, Sanders JB, Johnson WC et al (1965) Fibrous papule of the nose: a clinicopathological study. J Invest Dermatol 45:194–203
Harkin JC, Reed RJ (1969) Tumors of the peripheral nervous system. In: Atlas of tumor pathology series 2, fascicle 3. Armed Forces Institute of Pathology, Washington, DC, pp 60–64
Headington JT (1976) Tumors of the hair follicle: a review. Am J Pathol 85:479–514
Helwig EB (1963) Case 6-atypical fiboxanthoma. In: 18th annual tumor seminar of the San Antonio Society of Pathologist. Tex State J Med 59:664–667
Howard WR, Helwig EB (1960) Angiolipoma. Arch Dermatol 82:924–931
Hügel H (1991) Die plaqueförmige dermale Fibromatose. Hautarzt 42:223–226
Jarvi O, Saxen E (1961) Elastofibroma dorse. Acta Pathol Microbiol Scand 51(Suppl 144):83–84
Kamino H, Lee JY, Berke A (1989) Pleomorphic fibroma of the skin: a benign neoplasm with cytologic atypia. A clinicopathologic study of eight cases. Am J Surg Pathol 13:107–113
Keasbey LE (1953) Juvenile aponeurotic fibroma (calcifying fibroma): a distinctive tumor arising in the palms and soles of young children. Cancer 6:338–346
Klemperer P, Rabin CB (1931) Primary neoplasms of the pleura. A report of five cases. Arch Pathol 11:385–412
Kloepfer HW, Krafchuk J, Derbes V et al (1958) Hereditary multiple leiomyoma of the skin. Am J Hum Genet 10:48–52
Konwaler BE, Keasbey L, Kaplan L (1955) Subcutaneous pseudosarcomatous fibromatosis (fasciitis). Am J Clin Pathol 25:241–252
Larralde de Luna M, Riuz León J, Cabrera HN (1990) Pápules podálicas en el recién nacido. Med Cutan Ibero Lat Am 18:9–12
Launonen V, Vierimaa O, Kiuru M et al (2001) Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci U S A 98:3387–3392
Lister DM, Graham-Brown RA, Burns DA et al (1988) Collagenosis nuchae – a new entity? Clin Exp Dermatol 13:263–264
Lund HZ (1957) Tumors of the skin. In: Atlas of tumor pathology, 1st ser., fasc. 2. Armed Forces Institute of Pathology, Washington, DC, pp 274–277
Markel SF, Enzinger FM (1982) Neuromuscular hamartoma – a benign “triton tumor” composed of mature neural and striated muscle elements. Cancer 49:140–144
Marshall-Taylor C, Fanburg-Smith JC (2000) Hemosiderotic fibrohistiocytic lipomatous lesion: ten cases of a previously undescribed fatty lesion of the foot/ankle. Mod Pathol 13:1192–1199
Meis JM, Enzinger FM (1993) Chondroid lipoma. A unique tumor simulating liposarcoma and myxoid chondrosarcoma. Am J Surg Pathol 17:1103–1112
Mills AE (1989) Rhabdomyomatous mesenchymal hamartoma of skin. Am J Dermatopathol 11:58–63
Morton TG (1876) A peculiar and painful affection of the fourth metatarso-phalangeal articulation. Am J Med Sci 71:37–45
O’Brien JE, Stout AP (1964) Malignant fibrous xanthomas. Cancer 17:1445–1455
Pulitzer DR, Reed RJ (1985) Nerve-sheath myxoma (perineurial myxoma). Am J Dermatopathol 7:409–421
Rapini RP, Golitz LE (1989) Sclerotic fibromas of the skin. J Am Acad Dermatol 20:266–271
Reed RJ, Fine RM, Meltzer HD (1972) Palisaded, encapsulated neuromas of the skin. Arch Dermatol 106:865–870
Reed WB, Walker R, Horowitz R (1973) Cutaneous leiomyomata with uterine leiomyomata. Acta Derm Venereol 53:409–416
Regan JM, Bickel WH, Broders AC (1946) Infiltrating benign lipomas of the extremities. West J Surg Obstet Gynecol 54:87–93
Reye RD (1956) A consideration of certain subdermal fibromatous tumors of infancy. J Pathol Bacteriol 72:149–154
Reye RD (1965) Recurring digital fibrous tumors of childhood. Arch Pathol 80:228–231
Rodriguez-Jurado R, Palacios C, Durán-Mc Kinster C et al (2004) Medallion-like dermal dendrocyte hamartoma: a new clinically and histopathologically distinct lesion. J Am Acad Dermatol 51:359–363
Sahl WJ Jr (1978) Mobile encapsulated lipomas. Formerly called encapsulated angiolipomas. Arch Dermatol 114:1684–1686
Schwann T (1838) Ueber die Analogie in der Structur und dem Wachstum der Thiere und Pflanzen. Neue Not Geb Nat Heil 1838:33–36
Shmookler BM, Enzinger FM (1981) Pleomorphic lipoma: a benign tumor simulating liposarcoma. A clinicopathologic analysis of 48 cases. Cancer 47:126–133
Shmookler BM, Enzinger FM, Weiss SW (1989) Giant cell fibroblastoma. A juvenile form of dermatofibrosarcoma protuberans. Cancer 64:2154–2161
Silverman TA, Enzinger FM (1985) Fibrolipomatous hamartoma of nerve. Am J Surg Pathol 9:7–14
Smith NP, Wilson Jones E (1985) Multinucleate cell angiohistiocytoma – a new entity. Br J Dermatol 113(Suppl 29):15
Smolle J, Auboeck L, Gogg-Retzer I et al (1989) Multinucleate cell angiohistiocytoma: a clinicopathological, immunohistochemical and ultrastructural study. Br J Dermatol 121:113–121
Stout AP (1918) Tumor of the ulnar nerve. Proc NY Pathol Soc 18:2
Stout AP (1935) The peripheral manifestations of the specific nerve sheath tumor (neurolemmoma). Am J Cancer 24:751–796
Stout AP (1954) Juvenile fibromatoses. Cancer 7:953–978
Toker C (1972) Trabecular carcinoma of the skin. Arch Dermatol 105:107–110
Vellios F, Baez J, Shumacker HB (1958) Lipoblastomatosis: a tumor of fetal fat different from hibernoma. Am J Pathol 34:1149–1159
Weiss SW, Enzinger FM (1978) Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer 41:2250–2266
Worret WI, Burgdorf W (1978) Angeborenes plattenartiges Osteoma cutis bei einem Säugling. Hautarzt 29:590–596
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2020 Springer-Verlag GmbH Germany, part of Springer Nature
About this entry
Cite this entry
Wilk, M., Zelger, B. (2020). Mesenchymal and Neuronal Tumors. In: Plewig, G., French, L., Ruzicka, T., Kaufmann, R., Hertl, M. (eds) Braun-Falco´s Dermatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-58713-3_106-1
Download citation
DOI: https://doi.org/10.1007/978-3-662-58713-3_106-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-58713-3
Online ISBN: 978-3-662-58713-3
eBook Packages: Springer Reference MedicineReference Module Medicine